GR-MD-02
GT-028
Phase 2 small_molecule completed
Quick answer
GR-MD-02 for Nonalcoholic Steatohepatitis is a Phase 2 program (small_molecule) at GALECTIN THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GALECTIN THERAPEUTICS INC
- Indication
- Nonalcoholic Steatohepatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed